Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cumberland Pharmaceuticals (CPIX) Cash from Discontinued Operations (2019 - 2021)

Cumberland Pharmaceuticals (CPIX) has disclosed Cash from Discontinued Operations for 3 consecutive years, with 503318.0 as the latest value for Q4 2021.

  • Quarterly Cash from Discontinued Operations fell 62.78% to 503318.0 in Q4 2021 from the year-ago period, while the trailing twelve-month figure was 503318.0 through Sep 2022, down 82.3% year-over-year, with the annual reading at 1994322.0 for FY2021, 43.31% down from the prior year.
  • Cash from Discontinued Operations hit 503318.0 in Q4 2021 for Cumberland Pharmaceuticals, up from 496787.0 in the prior quarter.
  • In the past five years, Cash from Discontinued Operations ranged from a high of 3027800.0 in Q4 2019 to a low of 38567.0 in Q2 2020.
  • Historically, Cash from Discontinued Operations has averaged 918680.0 across 3 years, with a median of 648983.5 in 2020.
  • Biggest five-year swings in Cash from Discontinued Operations: tumbled 97.11% in 2020 and later skyrocketed 1193.35% in 2021.
  • Year by year, Cash from Discontinued Operations stood at 3027800.0 in 2019, then crashed by 55.34% to 1352156.0 in 2020, then plummeted by 62.78% to 503318.0 in 2021.
  • Business Quant data shows Cash from Discontinued Operations for CPIX at 503318.0 in Q4 2021, 496787.0 in Q3 2021, and 498807.0 in Q2 2021.